ecteinascidin 743 has been researched along with Genetic Predisposition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, H; Hasegawa, T; Sugita, S | 1 |
1 trial(s) available for ecteinascidin 743 and Genetic Predisposition
| Article | Year |
|---|---|
Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dioxoles; Genetic Predisposition to Disease; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Japan; Phenotype; Predictive Value of Tests; Sarcoma; Tetrahydroisoquinolines; Time Factors; Trabectedin; Translocation, Genetic; Treatment Outcome | 2016 |